mounjaro eli lilly - Search News

Eli Lilly launches anti-obesity drug in India

Reuters on MSN · 17h

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling with increasing rates of obesity and diabetes.

Markets Insider · 1d

Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover advantage in a market

The Times of India on MSN · 18h

Mounjaro: As Eli Lilly's blockbuster anti-obesity drug comes to India, expert lists key side effects

Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with weight management and activates hormone receptors. Potential side effects include gastrointestinal issues,

14h

Eli Lilly: Growth With Higher Margins

Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

4d

Eli Lilly wins final approval for $3B expansion in Pleasant Prairie

The vote clears the way for a proposed multibillion-dollar expansion of the former Nexus Pharmaceuticals facility.

3don MSN

Eli Lilly And Company (LLY): Among Stocks to Buy That May Be Splitting Soon

We recently published a list of the 12 Stocks to Buy That May Be Splitting Soon. In this article, we are going to take a look ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results